Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis

PURPOSE: Some studies have shown that Immune checkpoint inhibitors (ICIs) have a favorable efficacy in advanced triple negative breast cancer (TNBC) patients, but the results are controversial in neoadjuvant chemotherapy (NACT) stage. The purpose of this study is to evaluate the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Yuanfang, Shen, Guoshuang, Zheng, Yonghui, Guan, Yumei, Huo, Xingfa, Li, Jinming, Ren, Dengfeng, Zhao, Fuxing, Liu, Zhen, Li, Zitao, Zhao, Jiuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609839/
https://www.ncbi.nlm.nih.gov/pubmed/34814874
http://dx.doi.org/10.1186/s12885-021-08997-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609839/
https://www.ncbi.nlm.nih.gov/pubmed/34814874
http://dx.doi.org/10.1186/s12885-021-08997-w

Ejemplares similares